Cargando…

Chinese health biotech and the billion-patient market

Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.

Detalles Bibliográficos
Autores principales: Frew, Sarah E, Sammut, Stephen M, Shore, Alysha F, Ramjist, Joshua K, Al-Bader, Sara, Rezaie, Rahim, Daar, Abdallah S, Singer, Peter A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/
https://www.ncbi.nlm.nih.gov/pubmed/18183014
http://dx.doi.org/10.1038/nbt0108-37
_version_ 1783510930414370816
author Frew, Sarah E
Sammut, Stephen M
Shore, Alysha F
Ramjist, Joshua K
Al-Bader, Sara
Rezaie, Rahim
Daar, Abdallah S
Singer, Peter A
author_facet Frew, Sarah E
Sammut, Stephen M
Shore, Alysha F
Ramjist, Joshua K
Al-Bader, Sara
Rezaie, Rahim
Daar, Abdallah S
Singer, Peter A
author_sort Frew, Sarah E
collection PubMed
description Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7096943
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-70969432020-03-26 Chinese health biotech and the billion-patient market Frew, Sarah E Sammut, Stephen M Shore, Alysha F Ramjist, Joshua K Al-Bader, Sara Rezaie, Rahim Daar, Abdallah S Singer, Peter A Nat Biotechnol Article Chinese government support and 'sea turtles' are spurring the sector, but investors lack exits. SUPPLEMENTARY INFORMATION: The online version of this article (doi:10.1038/nbt0108-37) contains supplementary material, which is available to authorized users. Nature Publishing Group US 2008 /pmc/articles/PMC7096943/ /pubmed/18183014 http://dx.doi.org/10.1038/nbt0108-37 Text en © Nature Publishing Group 2008 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Frew, Sarah E
Sammut, Stephen M
Shore, Alysha F
Ramjist, Joshua K
Al-Bader, Sara
Rezaie, Rahim
Daar, Abdallah S
Singer, Peter A
Chinese health biotech and the billion-patient market
title Chinese health biotech and the billion-patient market
title_full Chinese health biotech and the billion-patient market
title_fullStr Chinese health biotech and the billion-patient market
title_full_unstemmed Chinese health biotech and the billion-patient market
title_short Chinese health biotech and the billion-patient market
title_sort chinese health biotech and the billion-patient market
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096943/
https://www.ncbi.nlm.nih.gov/pubmed/18183014
http://dx.doi.org/10.1038/nbt0108-37
work_keys_str_mv AT frewsarahe chinesehealthbiotechandthebillionpatientmarket
AT sammutstephenm chinesehealthbiotechandthebillionpatientmarket
AT shorealyshaf chinesehealthbiotechandthebillionpatientmarket
AT ramjistjoshuak chinesehealthbiotechandthebillionpatientmarket
AT albadersara chinesehealthbiotechandthebillionpatientmarket
AT rezaierahim chinesehealthbiotechandthebillionpatientmarket
AT daarabdallahs chinesehealthbiotechandthebillionpatientmarket
AT singerpetera chinesehealthbiotechandthebillionpatientmarket